Ikonisys S.A. (EPA:ALIKO)

France · Delayed Price · Currency is EUR

1.470

+0.020 (1.38%)

Oct 2, 2026, 5:25 PM CET

Market Cap	22.97M +13.0%
Revenue (ttm)	1.64M +62.2%
Net Income	-4.20M
EPS	n/a
Shares Out	15.84M
PE Ratio	n/a
Forward PE	48.33
Dividend	n/a
Ex-Dividend Date	n/a

Volume	11,547
Open	1.440
Previous Close	1.450
Day's Range	1.400 - 1.470
52-Week Range	1.300 - 1.840
Beta	0.69
Analysts	n/a
Price Target	n/a
Earnings Date	May 15, 2026

About Ikonisys

Ikonisys S.A., a cell-based diagnostics company, develops, produces, and markets medical diagnostic products for early and accurate detection of cancer diseases in the United States and Europe. It offers Ikoniscope Robotic Microscopes, including Ikoniscope20 that provides automated slide handling, slide scanning, and real-time image capture and analysis; and Ikoniscope20max that automates the fluorescence microscopy solution. The company also provides oncoFISH bladder that allows scanning and analysis of cells from a voided urine sample; oncoFI... [Read more]

Industry Medical Devices

Sector Healthcare

Founded 2021

Employees 15

Stock Exchange Euronext Paris

Ticker Symbol ALIKO

Full Company Profile

Financial Performance

In 2025, Ikonisys's revenue was 1.64 million, an increase of 62.23% compared to the previous year's 1.01 million. Losses were -4.20 million, 29.7% more than in 2024.

Financial Statements